Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment.

Boxer, A L

Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment. [electronic resource] - Neurology Apr 2005 - 1431-4 p. digital

Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.

1526-632X

10.1212/01.WNL.0000158476.74580.A8 doi


Adult
Anticoagulants--therapeutic use
Betaine--therapeutic use
Cognition Disorders--drug therapy
Confusion--drug therapy
Disease Progression
Drug Therapy, Combination
Folic Acid--therapeutic use
Frontal Lobe--metabolism
Homocysteine--antagonists & inhibitors
Humans
Hyperhomocysteinemia--complications
Leukoaraiosis--diagnosis
Magnetic Resonance Imaging
Male
Methylmalonic Acid--blood
Remission Induction
Seizures--drug therapy
Treatment Outcome
Vitamin B 12--metabolism
Vitamin B 6--therapeutic use